AI-Powered Embryo Selection Market Size, Share, Trend, Revenue Report 2026 to 2035
What is AI-Powered Embryo Selection Market Size?
Global AI-Powered Embryo Selection Market Size is valued at USD 183.74 Mn in 2025 and is predicted to reach USD 525.22 Mn by the year 2035 at a 11.2% CAGR during the forecast period for 2026 to 2035.
AI-Powered Embryo Selection Market Size, Share & Trends Analysis Distribution by Type (AI Predictive Analytics & Data Tools, AI Imaging & Scoring Platforms, IVF Lab Automation Systems with AI, AI Embryo Selection Software, and Support Modules / Integration Solutions), By Application (In Vitro Fertilization (IVF), Research & Clinical Trials, Cryopreservation & Embryo Storage, and Embryo Monitoring & Morphokinetic Analysis), and Segment Forecasts, 2026 to 2035.
An advanced use of AI in assisted reproductive technologies, namely in processes like in vitro fertilization (IVF), is AI-powered embryo selection. It entails analyzing photos and developmental data of embryos obtained via time-lapse imaging devices using machine learning techniques. Large datasets of both successful and unsuccessful embryo implantations are used to train these AI models to spot minute patterns that human embryologists can miss, like cell division timing, morphology, and growth dynamics. The AI-powered embryo selection market is primarily driven by the need to minimize subjectivity in embryology assessments, the demand for greater IVF success rates, and the rising prevalence of infertility worldwide.
The AI-powered embryo selection market is expanding significantly as a result of the growing need for higher in vitro fertilization success rates.
Globally, the number of IVF cycles has increased due to rising infertility rates, postponed childbearing, and shifting lifestyles. This has prompted the use of cutting-edge technologies that improve clinical outcomes. In order to set themselves apart from the competition and draw in patients looking for more dependable and effective treatments, fertility clinics are also increasingly incorporating time-lapse imaging and AI technologies. Additionally, the AI-powered embryo selection market is expanding more quickly due to rising awareness of technology-driven reproductive treatments and the desire to reduce the financial and emotional strain of repeated IVF cycles.
In addition, as artificial intelligence, data analytics, and imaging technologies continue to progress, the AI-powered embryo selection market is anticipated to change. Healthcare providers' increased investments and partnerships with AI firms are stimulating innovation and enhancing system accuracy. Although ethical issues and data privacy concerns continue to be major obstacles, regulatory advancements supporting digital health technology are also driving business expansion. Additionally, the market is progressively moving toward data-driven, customized reproductive treatments, where AI is crucial to maximizing results. AI-powered embryo selection is expected to become more widely used as knowledge grows and technology becomes more widely available, placing it as a game-changing answer in contemporary reproductive medicine.
Competitive Landscape
Which are the Leading Players in AI-Powered Embryo Selection Market?
- AIVF Ltd.
- Merck KGaA
- DeepLife AI
- Esco Lifesciences
- CooperSurgical
- Fairtility Ltd.
- Vitrolife AB
- TMRW Life Sciences
- Others
Market Dynamics
Driver
Increasing Progress in AI and Time-Lapse Imaging Technologies
The rapid development of artificial intelligence, especially in deep learning and computer vision, along with advancements in time-lapse embryo imaging systems used during in vitro fertilization, is a major factor propelling the AI-powered embryo selection market. Large volumes of accurate data are produced by modern incubators that continuously take high-resolution pictures of embryo development without affecting culture conditions. This data can be processed by AI systems to find minute developmental patterns that are frequently overlooked by human observation, such as morphokinetics and cell division timing. Additionally, AI is becoming a routine tool in next-generation reproductive care as a result of embryologists' growing trust in these technologies as they become more precise, easy to use, and clinically proven.
Restrain/Challenge
High Cost and Obstacles to Accessibility
The exorbitant expense of putting AI-powered embryo selection tools into practice is a major barrier in this market. Fertility clinics need to make investments in AI software platforms, sophisticated time-lapse imaging devices, and qualified staff to use and interpret these instruments. For small or mid-sized clinics, especially in developing nations, such investments may be unaffordable. Furthermore, these expenses are frequently transferred to patients, increasing the cost of therapies and restricting access for many couples. This problem is made worse by the lack of universal insurance coverage for IVF and similar cutting-edge technology. Because of this, the adoption of AI-powered solutions is still unequal despite their clinical benefits, and pricing continues to be a major obstacle to the AI-powered embryo selection market penetration.
IVF Lab Automation Systems with AI Segment is Expected to Drive the AI-Powered Embryo Selection Market
The IVF lab automation systems with AI segment held the largest share in the AI-powered embryo selection market in 2025, driven by the requirement for scalability, efficiency, and uniformity in in vitro fertilization labs. By automating various embryology procedures, such as gamete handling, embryo culture, and selection, these systems reduce human error and manual intervention. They do this by combining artificial intelligence, robotics, and sophisticated imaging. The need to manage massive datasets produced by time-lapse imaging and patient records, as well as rising IVF cycle numbers, is a further driver of growth. Automation powered by AI increases decision-making precision, streamlines workflow, and promotes reproducibility across clinics. Additionally, by automating repetitive procedures and facilitating remote monitoring and centralized analysis, automation helps alleviate the shortage of skilled embryologists.
In Vitro Fertilization (IVF) Segment is Growing at the Highest Rate in the AI-Powered Embryo Selection Market
In 2025, the In Vitro Fertilization (IVF) segment dominated the AI-powered embryo selection market. AI improves decision-making by offering data-driven insights into embryo viability, which increases implantation rates and decreases unsuccessful cycles because embryo selection is a crucial stage in IVF success. The demand for AI-based selection tools is directly fueled by the increasing number of IVF treatments performed worldwide, which are caused by infertility, lifestyle changes, and delayed pregnancies. Furthermore, AI is being used by fertility clinics to enhance clinical results, draw in more patients, and differentiate their offerings. This segment's dominance is being further strengthened by the integration of AI with time-lapse imaging systems in IVF labs, making it the main source of revenue for the AI-powered embryo selection market.
Why North America Led the AI-Powered Embryo Selection Market?
The AI-powered embryo selection market was dominated by North America region in 2025 because of the rapid development of IVF infrastructure, the growing use of improved embryo evaluation, and government-sponsored fertility programs. The United States has made significant progress as a result of its well-established fertility networks, early adoption of integrated imaging platforms, and ongoing innovation.
In order to lower cycle costs and increase implantation outcomes, prominent organizations in this region also use improved embryo selection technologies. Reliable algorithm training and validation are made possible by standardized digital imaging techniques across elite IVF facilities, while partnerships with developers guarantee integration with lab imaging systems and electronic medical records. Additionally, growing awareness of the advantages of software-based selection, physician preference for precision therapies, and improved integration of computational workflows and digital scanning are driving the AI-powered embryo selection market expansion.
Key Development:
• October 2025: In collaboration with Kai Health in South Korea, Hanahealth introduced Vita Embryo, an AI-powered embryo assessment tool, to IVF facilities in India to improve treatment outcomes and selection accuracy.
• August 2025: By integrating AI into its labs and launching Vita Embryo in 120 clinics across 65 cities, Nova IVF Fertility improved the accuracy and dependability of embryo selection for fertility treatments.
AI-Powered Embryo Selection Market Report Scope :
| Report Attribute | Specifications |
| Market size value in 2025 | USD 183.74 Mn |
| Revenue forecast in 2035 | USD 525.22 Mn |
| Growth Rate CAGR | CAGR of 11.2% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Mn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Type, By Application, and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | AIVF Ltd., Merck KGaA, DeepLife AI, Esco Lifesciences, CooperSurgical, Fairtility Ltd., Vitrolife AB, TMRW Life Sciences, and Others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentations of AI-Powered Embryo Selection Market :
AI-Powered Embryo Selection Market, by Type-
- AI Predictive Analytics & Data Tools
- AI Imaging & Scoring Platforms
- IVF Lab Automation Systems with AI
- AI Embryo Selection Software
- Support Modules / Integration Solutions
AI-Powered Embryo Selection Market, by Application-
- In Vitro Fertilization (IVF)
- Research & Clinical Trials
- Cryopreservation & Embryo Storage
- Embryo Monitoring & Morphokinetic Analysis
AI-Powered Embryo Selection Market, by Region-
- North America-
- The US
- Canada
- Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East and Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
AI-Powered Embryo Selection Market Size is valued at USD 183.74 Mn in 2025 and is predicted to reach USD 525.22 Mn by the year 2035
The AI-Powered Embryo Selection Market is expected to grow at a 11.2% CAGR during the forecast period for 2026 to 2035
AIVF Ltd., Merck KGaA, DeepLife AI, Esco Lifesciences, CooperSurgical, Fairtility Ltd., Vitrolife AB, TMRW Life Sciences, and Others
AI-Powered Embryo Selection Market is segmented into Type, Application, and Other.
North America region is leading the AI-Powered Embryo Selection Market.